Caricamento...
Deutetrabenazine in Tics Associated with Tourette Syndrome
BACKGROUND: Deutetrabenazine, an inhibitor of vesicular monoamine transporter type 2 (VMAT2) depletes presynaptic dopamine and is useful in the treatment of hyperkinetic movement disorders. This study explored the safety, tolerability, and preliminary efficacy of deutetrabenazine in adolescents with...
Salvato in:
| Pubblicato in: | Tremor Other Hyperkinet Mov (N Y) |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Columbia University Libraries/Information Services
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5133390/ https://ncbi.nlm.nih.gov/pubmed/27917309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7916/D8M32W3H |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|